Holger Liepmann
Chairman at F3 Platform Biologics, Inc.
Profile
Holger A.
Liepmann is currently the Chairman of F3 Platform Biologics, Inc. and a Director at PanTheryx, Inc., Desert Research Institute Foundation, and SmartTots.
He previously held positions as Chairman at Abbott GmbH (Germany), Director at Verenium Corp., Enzymotec Ltd., and Altan Pharma Ltd., and Executive Vice President at Abbott Laboratories and Pharmaceutical Products.
He was also a Senior Vice President at Abbott International LLC and a Marketing Manager-Europe at Cutter Laboratories, Inc. Liepmann received his undergraduate degree from Dartmouth College and his MBA from Stanford University.
Holger Liepmann active positions
| Companies | Position | Start |
|---|---|---|
Desert Research Institute Foundation
 Desert Research Institute Foundation Miscellaneous Commercial ServicesCommercial Services Desert Research Institute Foundation supports environmental science research to maximize DRI's impact on improving people's lives. It offers research in atmospheric, earth and ecosystem sciences. The company was founded in 1982 and is headquartered in Las Vegas, NV. | Director/Board Member | - |
| SmartTots | Director/Board Member | - |
PanTheryx, Inc.
 PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology PanTheryx, Inc. operates as a medical nutrition company that researches, develops, and commercializes medical nutrition products targeting the gastrointestinal microbiome. The firm offers medical foods, food for special dietary use, and dietary supplements. The company was founded by Tim Starzland and Bimla Starzl in 2007 and is headquartered in Boulder, CO. | Director/Board Member | 10/04/2020 |
F3 Platform Biologics, Inc.
 F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Chairman | - |
Former positions of Holger Liepmann
| Companies | Position | End |
|---|---|---|
Altan Pharma Ltd.
 Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Chief Operating Officer | 02/01/2021 |
| VERENIUM CORP | Director/Board Member | 31/10/2013 |
| Abbott International LLC | Corporate Officer/Principal | 02/01/2011 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2011 |
| Pharmaceutical Products | Corporate Officer/Principal | - |
Training of Holger Liepmann
| Dartmouth College | Undergraduate Degree |
| Stanford University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 11 |
|---|---|
Abbott GmbH (Germany)
 Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Health Technology |
| Cutter Laboratories, Inc. | |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Verenium Corp. produces cellulosic ethanol derived from multiple biomass feedstocks. It manufactures and markets enzyme products in the fields of animal health and nutrition, grain processing, oilseed processing, oilfield services and other industrial processes such as pulp and paper and textiles. The company was founded in December 1992 and is headquartered in San Diego, CA. | Health Technology |
Enzymotec Ltd.
 Enzymotec Ltd. BiotechnologyHealth Technology Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. | Health Technology |
Desert Research Institute Foundation
Desert Research Institute Foundation Miscellaneous Commercial ServicesCommercial Services Desert Research Institute Foundation supports environmental science research to maximize DRI's impact on improving people's lives. It offers research in atmospheric, earth and ecosystem sciences. The company was founded in 1982 and is headquartered in Las Vegas, NV. | Commercial Services |
| Abbott International LLC | |
| Pharmaceutical Products | |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Health Technology |
| SmartTots | |
PanTheryx, Inc.
PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology PanTheryx, Inc. operates as a medical nutrition company that researches, develops, and commercializes medical nutrition products targeting the gastrointestinal microbiome. The firm offers medical foods, food for special dietary use, and dietary supplements. The company was founded by Tim Starzland and Bimla Starzl in 2007 and is headquartered in Boulder, CO. | Health Technology |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Holger Liepmann
